Matches in Wikidata for { <http://www.wikidata.org/entity/Q49873408> ?p ?o ?g. }
- Q49873408 description "2018 nî lūn-bûn" @default.
- Q49873408 description "2018年の論文" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年学术文章" @default.
- Q49873408 description "2018年學術文章" @default.
- Q49873408 description "2018年學術文章" @default.
- Q49873408 description "2018年學術文章" @default.
- Q49873408 description "2018年學術文章" @default.
- Q49873408 description "2018年學術文章" @default.
- Q49873408 description "2018년 논문" @default.
- Q49873408 description "article científic" @default.
- Q49873408 description "article scientific" @default.
- Q49873408 description "article scientifique" @default.
- Q49873408 description "articol științific" @default.
- Q49873408 description "articolo scientifico" @default.
- Q49873408 description "artigo científico" @default.
- Q49873408 description "artigo científico" @default.
- Q49873408 description "artigo científico" @default.
- Q49873408 description "artikel ilmiah" @default.
- Q49873408 description "artikull shkencor" @default.
- Q49873408 description "artikulong pang-agham" @default.
- Q49873408 description "artykuł naukowy" @default.
- Q49873408 description "artículo científico publicado en 2018" @default.
- Q49873408 description "artículu científicu" @default.
- Q49873408 description "bilimsel makale" @default.
- Q49873408 description "bài báo khoa học" @default.
- Q49873408 description "naučni članak" @default.
- Q49873408 description "scienca artikolo" @default.
- Q49873408 description "scientific article published on 22 January 2018" @default.
- Q49873408 description "scientific article published on 22 January 2018" @default.
- Q49873408 description "scientific article published on 22 January 2018" @default.
- Q49873408 description "teaduslik artikkel" @default.
- Q49873408 description "tieteellinen artikkeli" @default.
- Q49873408 description "tudományos cikk" @default.
- Q49873408 description "vedecký článok" @default.
- Q49873408 description "vetenskaplig artikel" @default.
- Q49873408 description "videnskabelig artikel" @default.
- Q49873408 description "vitenskapelig artikkel" @default.
- Q49873408 description "vitskapeleg artikkel" @default.
- Q49873408 description "vědecký článek" @default.
- Q49873408 description "wetenschappelijk artikel" @default.
- Q49873408 description "wissenschaftlicher Artikel" @default.
- Q49873408 description "επιστημονικό άρθρο" @default.
- Q49873408 description "мақолаи илмӣ" @default.
- Q49873408 description "наукова стаття, опублікована в січні 2018" @default.
- Q49873408 description "научна статия" @default.
- Q49873408 description "научная статья" @default.
- Q49873408 description "научни чланак" @default.
- Q49873408 description "научни чланак" @default.
- Q49873408 description "מאמר מדעי" @default.
- Q49873408 description "مقالة علمية نشرت في 22 يناير 2018" @default.
- Q49873408 description "২২ জানুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q49873408 description "บทความทางวิทยาศาสตร์" @default.
- Q49873408 description "სამეცნიერო სტატია" @default.
- Q49873408 name "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 name "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 type Item @default.
- Q49873408 label "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 label "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 prefLabel "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 prefLabel "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 P1433 Q49873408-845E7429-907C-4B34-A495-537E355E234D @default.
- Q49873408 P1476 Q49873408-843E5B2A-E066-4BE3-A70E-9CAAB113BCC5 @default.
- Q49873408 P2093 Q49873408-20FD4CC3-3791-4CE4-B141-D9929B680CDA @default.
- Q49873408 P2093 Q49873408-58A07FB6-CCFC-47B3-B9CB-32EB35706845 @default.
- Q49873408 P2093 Q49873408-72860487-FBD2-49B3-A769-B5385C83B3C8 @default.
- Q49873408 P2093 Q49873408-74AAE438-8C1E-46E7-981B-D26F69CEBE83 @default.
- Q49873408 P2093 Q49873408-87E42ACF-B1EF-406C-B952-1ED33DD00D8E @default.
- Q49873408 P2093 Q49873408-9D46FDED-8511-4B9F-8791-0E5FAF566B20 @default.
- Q49873408 P2093 Q49873408-B35F30D8-D1DE-4EE6-AFE8-7250C4E400AA @default.
- Q49873408 P2093 Q49873408-B3B82E86-B4FF-465D-B978-E815A6F0CBB1 @default.
- Q49873408 P2093 Q49873408-C59410FF-C676-441A-BC10-9B848AA42C6B @default.
- Q49873408 P2093 Q49873408-CD7F1605-982F-4B51-9D40-4E78ED334094 @default.
- Q49873408 P2093 Q49873408-CE5F0CDE-F648-4A38-A725-A4537F09AD88 @default.
- Q49873408 P2093 Q49873408-DFE2F85A-67B5-45A2-A945-6612D4C2FD8E @default.
- Q49873408 P2093 Q49873408-E5F85F20-BC9F-4720-8C34-367006419837 @default.
- Q49873408 P2093 Q49873408-ED02B732-1203-4BC7-A641-EFEF24FF4B50 @default.
- Q49873408 P31 Q49873408-EAE72FB5-901D-4D40-B85F-6D4C21FEA366 @default.
- Q49873408 P356 Q49873408-E8CF4BC6-E398-4BBB-B98E-FE26B96E6D8A @default.
- Q49873408 P407 Q49873408-E30E9F56-A6D7-4A9A-974B-3A16E87EF1D3 @default.
- Q49873408 P50 Q49873408-2E993778-FC22-44CF-8F3B-5181B7F3A3B7 @default.
- Q49873408 P50 Q49873408-6899570F-F0FD-4DE9-A6BF-40E41A919D63 @default.
- Q49873408 P50 Q49873408-D78189D2-B796-41AB-AF34-F4C3C43ABF22 @default.
- Q49873408 P577 Q49873408-BED6ABB2-BFA7-4D2A-A04E-09EE846F7763 @default.
- Q49873408 P698 Q49873408-72408DC2-0C9C-4496-910A-615706A3DCDE @default.
- Q49873408 P921 Q49873408-302B1346-BA10-4AAD-BBE8-00751C53119A @default.
- Q49873408 P921 Q49873408-37EF91BC-155B-4557-8017-3D78E2D1A3DC @default.
- Q49873408 P921 Q49873408-6E5BF551-25EF-4A35-8424-F8BC466EA64F @default.
- Q49873408 P356 1078-0432.CCR-17-3436 @default.
- Q49873408 P698 29358500 @default.
- Q49873408 P1433 Q332253 @default.
- Q49873408 P1476 "Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study." @default.
- Q49873408 P2093 "Blanca Homet Moreno" @default.
- Q49873408 P2093 "David McDermott" @default.
- Q49873408 P2093 "Deborah Jean Lee Wong" @default.
- Q49873408 P2093 "Donald P Lawrence" @default.